Table 4.
Clinical examinations of enrolled patients.
| Parameter | Reference | Populations (n=182) |
|---|---|---|
| ESR (mm/h) | Normal (0–22 for M and 0–29 for F) | 180 (99) |
| Abnormal (>22 for M and >29 for F) | 2 (1) | |
| CRP (mg/dL) | <3 | 179 (98) |
| ≥3 | 3 (2) | |
| CH50 (U/mL) | >41 but <90 | 180 (99) |
| ≥90 | 2 (1) | |
| C1 (mg/dL) | >16 but <31 | 181 (99) |
| ≥31 | 1 (1) | |
| C-3 (mg/dL) | Normal (≥88 but <252 for M and ≥88 but <206 for F) | 179 (98) |
| Abnormal (≥252 for M and ≥206 for F) | 3 (2) | |
| C-4 (mg/dL) | Normal (≥12 but <72 for M and ≥13 but <75 for F) | 180 (99) |
| Abnormal (≥72 for M and ≥75 for F) | 2 (1) | |
| Anti-nuclear antibody | Positive | 0 (0) |
| Negative | 182 (100) | |
| Anti-RNP antibody | Positive | 0 (0) |
| Negative | 182 (100) | |
| Anti-Ro/La antibody | Positive | 0 (0) |
| Negative | 182 (100) | |
| Anti-Sm antibody | Positive | 0 (0) |
| Negative | 182 (100) | |
| Anti-ribosomal P antibody | Positive | 0 (0) |
| Negative | 182 (100) | |
| Anti-histone antibody | Positive | 0 (0) |
| Negative | 182 (100) | |
| Anti-β2 GPI antibody | Positive | 0 (0) |
| Negative | 182 (100) | |
| Anti-cardiolipin antibody | Positive | 0 (0) |
| Negative | 182 (100) | |
| Rheumatoid factor (IU/mL) | <15 | 3 (2) |
| ≥15 | 179 (98) |
Data were represented as number (percentage). M – Male; F – Female; ESR – erythrocyte sedimentation rate; CRP – C-reactive protein; CH50 – hemolytic complement; C – complement component.